Literature DB >> 23141615

Vaccination for whom? Time to reinvigorate Japanese vaccine policy.

Tetsuya Tanimoto, Naoko Murashige, Miwako Hosoda, Eiji Kusumi, Shunsuke Ono, Masahiro Kami, Kenji Shibuya.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23141615     DOI： 10.1016/S0140-6736(12)61948-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Mistrust surrounding vaccination recommendations by the Japanese government: results from a national survey of working-age individuals.

Authors:  Koji Wada; Derek R Smith
Journal:  BMC Public Health       Date:  2015-04-26       Impact factor: 3.295

2.  Concerns about unapproved meningococcal vaccination for eculizumab therapy in Japan.

Authors:  Tetsuya Tanimoto; Eiji Kusumi; Kazutaka Hosoda; Kaduki Kouno; Tamae Hamaki; Masahiro Kami
Journal:  Orphanet J Rare Dis       Date:  2014-04-10       Impact factor: 4.123

Review 3.  A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan.

Authors:  Tetsuya Tanimoto
Journal:  Drug Des Devel Ther       Date:  2015-03-31       Impact factor: 4.162

4.  Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals.

Authors:  Yvonne E Thomassen; Aart G van 't Oever; Monique G C T van Oijen; René H Wijffels; Leo A van der Pol; Wilfried A M Bakker
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.